trial · primary record
Sodium Nitrate
Kidney Injury, Acute
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2026-12-30 |
| Primary endpoint | Percent of participants receiving the first dose of blinded study drug within 1-8 hours prior to contrast exposure |
| Registry ID | NCT07016074 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:39.337Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07016074
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.